{
    "relation": [
        [
            "",
            "Total, other (not including serious) adverse events",
            "# participants affected / at risk",
            "Blood and lymphatic system disorders",
            "Anemia * 1",
            "# participants affected / at risk",
            "Endocrine disorders",
            "Hypothyroidism * 1",
            "# participants affected / at risk",
            "Gastrointestinal disorders",
            "Abdominal pain * 1",
            "# participants affected / at risk",
            "Constipation * 1",
            "# participants affected / at risk",
            "Diarrhea * 1",
            "# participants affected / at risk",
            "Dyspepsia * 1",
            "# participants affected / at risk",
            "Dry mouth * 1",
            "# participants affected / at risk",
            "Mucositis oral * 1",
            "# participants affected / at risk",
            "Nausea * 1",
            "# participants affected / at risk",
            "Gastrointestinal disorders - Other * 1",
            "# participants affected / at risk",
            "Vomiting * 1",
            "# participants affected / at risk",
            "General disorders",
            "Edema limbs * 1",
            "# participants affected / at risk",
            "Fatigue * 1",
            "# participants affected / at risk",
            "Fever * 1",
            "# participants affected / at risk",
            "Flu like symptoms * 1",
            "# participants affected / at risk",
            "Pain * 1",
            "# participants affected / at risk",
            "Infections and infestations",
            "Infections and infestations - Other * 1",
            "# participants affected / at risk",
            "Rash pustular * 1",
            "# participants affected / at risk",
            "Upper respiratory infection * 1",
            "# participants affected / at risk",
            "Urinary tract infection * 1",
            "# participants affected / at risk",
            "Investigations",
            "Alanine aminotransferase increased * 1",
            "# participants affected / at risk",
            "Alkaline phosphatase increased * 1",
            "# participants affected / at risk",
            "Aspartate aminotransferase increased * 1",
            "# participants affected / at risk",
            "Blood bilirubin increased * 1",
            "# participants affected / at risk",
            "Neutrophil count decreased * 1",
            "# participants affected / at risk",
            "Investigations - Other * 1",
            "# participants affected / at risk",
            "Platelet count decreased * 1",
            "# participants affected / at risk",
            "Weight loss * 1",
            "# participants affected / at risk",
            "Metabolism and nutrition disorders",
            "Anorexia * 1",
            "# participants affected / at risk",
            "Hypoalbuminemia * 1",
            "# participants affected / at risk",
            "Hypokalemia * 1",
            "# participants affected / at risk",
            "Hyponatremia * 1",
            "# participants affected / at risk",
            "Hypophosphatemia * 1",
            "# participants affected / at risk",
            "Hyperglycemia * 1",
            "# participants affected / at risk",
            "Musculoskeletal and connective tissue disorders",
            "Back pain * 1",
            "# participants affected / at risk",
            "Myalgia * 1",
            "# participants affected / at risk",
            "Pain in extremity * 1",
            "# participants affected / at risk",
            "Nervous system disorders",
            "Dysgeusia * 1",
            "# participants affected / at risk",
            "Headache * 1",
            "# participants affected / at risk",
            "Peripheral sensory neuropathy * 1",
            "# participants affected / at risk",
            "Renal and urinary disorders",
            "Proteinuria * 1",
            "# participants affected / at risk",
            "Respiratory, thoracic and mediastinal disorders",
            "Cough * 1",
            "# participants affected / at risk",
            "Dyspnea * 1",
            "# participants affected / at risk",
            "Epistaxis * 1",
            "# participants affected / at risk",
            "Hoarseness * 1",
            "# participants affected / at risk",
            "Voice alteration * 1",
            "# participants affected / at risk",
            "Skin and subcutaneous tissue disorders",
            "Alopecia * 1",
            "# participants affected / at risk",
            "Dry skin * 1",
            "# participants affected / at risk",
            "Erythema multiforme * 1",
            "# participants affected / at risk",
            "Erythroderma * 1",
            "# participants affected / at risk",
            "Skin and subcutaneous tissue disorders - Other * 1",
            "# participants affected / at risk",
            "Pain of skin * 1",
            "# participants affected / at risk",
            "Palmar-plantar erythrodysesthesia syndrome * 1",
            "# participants affected / at risk",
            "Pruritus * 1",
            "# participants affected / at risk",
            "Rash acneiform * 1",
            "# participants affected / at risk",
            "Rash maculo-papular * 1",
            "# participants affected / at risk",
            "Vascular disorders",
            "Hypertension * 1",
            "# participants affected / at risk"
        ],
        [
            "Regorafenib (Double Blind Only)",
            "",
            "131/132 (99.24%)",
            "",
            "",
            "14/132 (10.61%)",
            "",
            "",
            "19/132 (14.39%)",
            "",
            "",
            "33/132 (25.00%)",
            "",
            "36/132 (27.27%)",
            "",
            "60/132 (45.45%)",
            "",
            "7/132 (5.30%)",
            "",
            "8/132 (6.06%)",
            "",
            "54/132 (40.91%)",
            "",
            "26/132 (19.70%)",
            "",
            "8/132 (6.06%)",
            "",
            "22/132 (16.67%)",
            "",
            "",
            "6/132 (4.55%)",
            "",
            "66/132 (50.00%)",
            "",
            "28/132 (21.21%)",
            "",
            "7/132 (5.30%)",
            "",
            "20/132 (15.15%)",
            "",
            "",
            "8/132 (6.06%)",
            "",
            "9/132 (6.82%)",
            "",
            "12/132 (9.09%)",
            "",
            "7/132 (5.30%)",
            "",
            "",
            "9/132 (6.82%)",
            "",
            "6/132 (4.55%)",
            "",
            "12/132 (9.09%)",
            "",
            "13/132 (9.85%)",
            "",
            "6/132 (4.55%)",
            "",
            "6/132 (4.55%)",
            "",
            "8/132 (6.06%)",
            "",
            "18/132 (13.64%)",
            "",
            "",
            "40/132 (30.30%)",
            "",
            "6/132 (4.55%)",
            "",
            "5/132 (3.79%)",
            "",
            "4/132 (3.03%)",
            "",
            "7/132 (5.30%)",
            "",
            "5/132 (3.79%)",
            "",
            "",
            "12/132 (9.09%)",
            "",
            "21/132 (15.91%)",
            "",
            "14/132 (10.61%)",
            "",
            "",
            "11/132 (8.33%)",
            "",
            "20/132 (15.15%)",
            "",
            "8/132 (6.06%)",
            "",
            "",
            "10/132 (7.58%)",
            "",
            "",
            "11/132 (8.33%)",
            "",
            "8/132 (6.06%)",
            "",
            "3/132 (2.27%)",
            "",
            "32/132 (24.24%)",
            "",
            "16/132 (12.12%)",
            "",
            "",
            "32/132 (24.24%)",
            "",
            "8/132 (6.06%)",
            "",
            "7/132 (5.30%)",
            "",
            "5/132 (3.79%)",
            "",
            "11/132 (8.33%)",
            "",
            "8/132 (6.06%)",
            "",
            "75/132 (56.82%)",
            "",
            "11/132 (8.33%)",
            "",
            "7/132 (5.30%)",
            "",
            "24/132 (18.18%)",
            "",
            "",
            "77/132 (58.33%)"
        ],
        [
            "Placebo ( Double Blind Only)",
            "",
            "60/66 (90.91%)",
            "",
            "",
            "4/66 (6.06%)",
            "",
            "",
            "2/66 (3.03%)",
            "",
            "",
            "10/66 (15.15%)",
            "",
            "15/66 (22.73%)",
            "",
            "6/66 (9.09%)",
            "",
            "2/66 (3.03%)",
            "",
            "3/66 (4.55%)",
            "",
            "5/66 (7.58%)",
            "",
            "8/66 (12.12%)",
            "",
            "3/66 (4.55%)",
            "",
            "5/66 (7.58%)",
            "",
            "",
            "7/66 (10.61%)",
            "",
            "25/66 (37.88%)",
            "",
            "7/66 (10.61%)",
            "",
            "1/66 (1.52%)",
            "",
            "13/66 (19.70%)",
            "",
            "",
            "0/66 (0.00%)",
            "",
            "0/66 (0.00%)",
            "",
            "0/66 (0.00%)",
            "",
            "2/66 (3.03%)",
            "",
            "",
            "1/66 (1.52%)",
            "",
            "3/66 (4.55%)",
            "",
            "3/66 (4.55%)",
            "",
            "2/66 (3.03%)",
            "",
            "3/66 (4.55%)",
            "",
            "3/66 (4.55%)",
            "",
            "0/66 (0.00%)",
            "",
            "5/66 (7.58%)",
            "",
            "",
            "14/66 (21.21%)",
            "",
            "0/66 (0.00%)",
            "",
            "2/66 (3.03%)",
            "",
            "3/66 (4.55%)",
            "",
            "0/66 (0.00%)",
            "",
            "4/66 (6.06%)",
            "",
            "",
            "3/66 (4.55%)",
            "",
            "8/66 (12.12%)",
            "",
            "3/66 (4.55%)",
            "",
            "",
            "2/66 (3.03%)",
            "",
            "6/66 (9.09%)",
            "",
            "1/66 (1.52%)",
            "",
            "",
            "1/66 (1.52%)",
            "",
            "",
            "6/66 (9.09%)",
            "",
            "3/66 (4.55%)",
            "",
            "0/66 (0.00%)",
            "",
            "4/66 (6.06%)",
            "",
            "2/66 (3.03%)",
            "",
            "",
            "1/66 (1.52%)",
            "",
            "0/66 (0.00%)",
            "",
            "1/66 (1.52%)",
            "",
            "0/66 (0.00%)",
            "",
            "1/66 (1.52%)",
            "",
            "1/66 (1.52%)",
            "",
            "9/66 (13.64%)",
            "",
            "8/66 (12.12%)",
            "",
            "0/66 (0.00%)",
            "",
            "2/66 (3.03%)",
            "",
            "",
            "18/66 (27.27%)"
        ],
        [
            "Regorafenib, Open Label Only (Regorafenib Continued)",
            "",
            "31/41 (75.61%)",
            "",
            "",
            "2/41 (4.88%)",
            "",
            "",
            "2/41 (4.88%)",
            "",
            "",
            "6/41 (14.63%)",
            "",
            "7/41 (17.07%)",
            "",
            "8/41 (19.51%)",
            "",
            "2/41 (4.88%)",
            "",
            "0/41 (0.00%)",
            "",
            "2/41 (4.88%)",
            "",
            "6/41 (14.63%)",
            "",
            "0/41 (0.00%)",
            "",
            "4/41 (9.76%)",
            "",
            "",
            "3/41 (7.32%)",
            "",
            "5/41 (12.20%)",
            "",
            "3/41 (7.32%)",
            "",
            "2/41 (4.88%)",
            "",
            "3/41 (7.32%)",
            "",
            "",
            "3/41 (7.32%)",
            "",
            "0/41 (0.00%)",
            "",
            "1/41 (2.44%)",
            "",
            "2/41 (4.88%)",
            "",
            "",
            "4/41 (9.76%)",
            "",
            "3/41 (7.32%)",
            "",
            "5/41 (12.20%)",
            "",
            "2/41 (4.88%)",
            "",
            "2/41 (4.88%)",
            "",
            "3/41 (7.32%)",
            "",
            "0/41 (0.00%)",
            "",
            "2/41 (4.88%)",
            "",
            "",
            "5/41 (12.20%)",
            "",
            "1/41 (2.44%)",
            "",
            "0/41 (0.00%)",
            "",
            "0/41 (0.00%)",
            "",
            "0/41 (0.00%)",
            "",
            "1/41 (2.44%)",
            "",
            "",
            "2/41 (4.88%)",
            "",
            "3/41 (7.32%)",
            "",
            "1/41 (2.44%)",
            "",
            "",
            "0/41 (0.00%)",
            "",
            "2/41 (4.88%)",
            "",
            "1/41 (2.44%)",
            "",
            "",
            "8/41 (19.51%)",
            "",
            "",
            "1/41 (2.44%)",
            "",
            "2/41 (4.88%)",
            "",
            "2/41 (4.88%)",
            "",
            "2/41 (4.88%)",
            "",
            "0/41 (0.00%)",
            "",
            "",
            "5/41 (12.20%)",
            "",
            "1/41 (2.44%)",
            "",
            "0/41 (0.00%)",
            "",
            "0/41 (0.00%)",
            "",
            "3/41 (7.32%)",
            "",
            "0/41 (0.00%)",
            "",
            "12/41 (29.27%)",
            "",
            "2/41 (4.88%)",
            "",
            "0/41 (0.00%)",
            "",
            "3/41 (7.32%)",
            "",
            "",
            "9/41 (21.95%)"
        ],
        [
            "Placebo, Open Label Only (Switch to Regorafenib)",
            "",
            "55/56 (98.21%)",
            "",
            "",
            "7/56 (12.50%)",
            "",
            "",
            "4/56 (7.14%)",
            "",
            "",
            "11/56 (19.64%)",
            "",
            "12/56 (21.43%)",
            "",
            "15/56 (26.79%)",
            "",
            "2/56 (3.57%)",
            "",
            "3/56 (5.36%)",
            "",
            "17/56 (30.36%)",
            "",
            "13/56 (23.21%)",
            "",
            "1/56 (1.79%)",
            "",
            "3/56 (5.36%)",
            "",
            "",
            "8/56 (14.29%)",
            "",
            "22/56 (39.29%)",
            "",
            "9/56 (16.07%)",
            "",
            "1/56 (1.79%)",
            "",
            "11/56 (19.64%)",
            "",
            "",
            "2/56 (3.57%)",
            "",
            "2/56 (3.57%)",
            "",
            "4/56 (7.14%)",
            "",
            "1/56 (1.79%)",
            "",
            "",
            "5/56 (8.93%)",
            "",
            "2/56 (3.57%)",
            "",
            "8/56 (14.29%)",
            "",
            "7/56 (12.50%)",
            "",
            "4/56 (7.14%)",
            "",
            "1/56 (1.79%)",
            "",
            "3/56 (5.36%)",
            "",
            "5/56 (8.93%)",
            "",
            "",
            "13/56 (23.21%)",
            "",
            "3/56 (5.36%)",
            "",
            "7/56 (12.50%)",
            "",
            "3/56 (5.36%)",
            "",
            "1/56 (1.79%)",
            "",
            "3/56 (5.36%)",
            "",
            "",
            "1/56 (1.79%)",
            "",
            "9/56 (16.07%)",
            "",
            "3/56 (5.36%)",
            "",
            "",
            "3/56 (5.36%)",
            "",
            "8/56 (14.29%)",
            "",
            "2/56 (3.57%)",
            "",
            "",
            "5/56 (8.93%)",
            "",
            "",
            "8/56 (14.29%)",
            "",
            "4/56 (7.14%)",
            "",
            "3/56 (5.36%)",
            "",
            "9/56 (16.07%)",
            "",
            "8/56 (14.29%)",
            "",
            "",
            "16/56 (28.57%)",
            "",
            "1/56 (1.79%)",
            "",
            "1/56 (1.79%)",
            "",
            "3/56 (5.36%)",
            "",
            "5/56 (8.93%)",
            "",
            "1/56 (1.79%)",
            "",
            "33/56 (58.93%)",
            "",
            "4/56 (7.14%)",
            "",
            "1/56 (1.79%)",
            "",
            "6/56 (10.71%)",
            "",
            "",
            "29/56 (51.79%)"
        ]
    ],
    "pageTitle": "Study of Regorafenib as a 3rd-line or Beyond Treatment for Gastrointestinal Stromal Tumors (GIST) - Study Results - ClinicalTrials.gov",
    "title": "",
    "url": "https://clinicaltrials.gov/ct2/show/results/NCT01271712?sect=X46015&view=results",
    "hasHeader": true,
    "headerPosition": "FIRST_ROW",
    "tableType": "RELATION",
    "tableNum": 25,
    "s3Link": "common-crawl/crawl-data/CC-MAIN-2015-32/segments/1438042986357.49/warc/CC-MAIN-20150728002306-00248-ip-10-236-191-2.ec2.internal.warc.gz",
    "recordEndOffset": 858743975,
    "recordOffset": 858724563,
    "tableOrientation": "HORIZONTAL",
    "textBeforeTable": "Period 1: \u00a0 Double Blind Treatment Participant Flow for 4 periods Double blind phase: participants received matching Placebo tablets per os once daily, 3 weeks on therapy followed by 1 week off therapy to comprise a cycle of 4 weeks. Open Label phase: participants on placebo who switched to Regorafenib, received Regorafenib 160 mg (4 x 40 mg tablets) per os once daily, 3 weeks on therapy followed by 1 week off therapy to comprise a cycle of 4 weeks. Placebo First, Then Option of Open Label Regorafenib Treatment Participants received Regorafenib (Stivarga) 160 mg (4 x 40 mg tablets) per os once daily, 3 weeks on therapy followed by 1 week off therapy to comprise a cycle of 4 weeks Regorafenib (Stivarga, BAY73-4506) Description \u00a0 Reporting Groups Participants were randomized in a 2:1 ratio to receive either regorafenib (133 patients) or placebo (66 patients). Randomization was stratified according 3rd vs. 4th line of therapy (at least 50% of patients were to be 3rd line), and geographical region (Asia vs.rest of world). Significant events and approaches for the overall study following participant enrollment, but prior to group",
    "textAfterTable": "\u00a0 \u00a0 # participants affected / at risk \u00a0 \u00a0 7/132\u00a0(5.30%) \u00a0 \u00a0 2/66\u00a0(3.03%) \u00a0 \u00a0 2/41\u00a0(4.88%) \u00a0 \u00a0 1/56\u00a0(1.79%) \u00a0 Investigations \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 Alanine aminotransferase increased * 1 \u00a0 \u00a0 \u00a0 \u00a0 # participants affected / at risk \u00a0 \u00a0 9/132\u00a0(6.82%) \u00a0 \u00a0 1/66\u00a0(1.52%) \u00a0 \u00a0 4/41\u00a0(9.76%) \u00a0 \u00a0 5/56\u00a0(8.93%) \u00a0 Alkaline phosphatase increased * 1 \u00a0 \u00a0 \u00a0 \u00a0 # participants affected / at risk \u00a0",
    "hasKeyColumn": true,
    "keyColumnIndex": 0,
    "headerRowIndex": 0
}